Prostate Cancer Treatment

The Screening for More Prostate Cancer Diagnoses becomes Increasingly Controversial

Prostate Cancer Treatment

Screening Prostate Cancer Controversy

A controversial topic for at least 20 years, the screening men for prostate cancer – It is believed by many clinicians for most tumors that finding a tumor early and cutting it out is the best possible method to treat prostate cancer.

It is recommended for men with a family history of prostate cancer get screened for the disease more often. Critics of the screening have argued that frequent screenings make it more likely a prostate tumor will be found – including tumors that are not dangerous.

Early treatment can cause more damage than leaving the tumor alone; many prostate tumors grow so slowly that the patient is to die of other causes before the tumor becomes a threat.

Whether men with a brother or father with the disease more likely to have a tumor diagnosis because of genetic or to be screened. Sweden, Thursday – a new study released that the answer was a little of both.

Without any obvious benefit, screening men for prostate cancer can lead debilitating, painful, and expensive medical treatments.

A man dying from prostate cancer is about 3% but the lifetime risk of being diagnosed with prostate cancer has nearly doubled from about 9% to 16%, a proportion that has remained constant for at least three decades.

That’s why prostate cancer screening is such a challenging issue. It may harm many others along the way, but it will save some men’s life.

There is still some uncertainty yet whether screening saves any lives. As such, the decision to screen is likely to remain one made by doctor and patient, with both unsure whether or not the test is risky or prudent.

In constraint, the treatment’s side effect is much less severe for women with breast cancer must be treated; only 11 women to save two lives. Women can get reconstructive surgery and suffer fewer permanent effects, while man suffers long-term impotence and urinary incontinence.

Randomized trials of prostate cancer screening were published two weeks ago, the result of two large. The studies represented an enormous research effort: involving more than a quarter of a million men and many millions of dollars, almost 20 years of work.

The U.S study said no; the European study said yes.

It is said on the reported online in the Journal of The National Cancer Institute that men with a father or brother who had been diagnosed with prostate cancer had three times the normal risk of being diagnosed with a tumor themselves.

If doctors didn’t go looking for them that would never be found and produce the symptoms. That was attributable to finding low-grade non-aggressive tumors of the sort.

Incoming search terms:

    screening for cancer

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>